Genetic evidence suggests that abnormal SMN1/2 gene copy numbers modulate the risk and severity of ALS humans whereas SMN overexpression delays motor neuron loss in SOD1(G93A) ALS mice49–51. Here, SMN1 is linked to amyotrophic lateral sclerosis.